argyrotsipi/train-dataset huggingface dataset:
Defence Supplementary Estimate 2021-22 — House of Commons, 2022-03-09
Topic: Defense
David Michael Doogan (Scottish National Party, Centre-left): There is a lot of chest-beating about the nuclear deterrent, but much less discussion about the cost of it. We have heard from hon. and gallant Members how much they would like to see numbers in the Army go up, but they do not talk so much about the cost of the Defence Nuclear Organisation, which is 50% higher than that of the next department, the Army. They are not so focused on that cost. Incidentally, I note the Minister in his intervention did not point out which surface warships there are in Scotland, because there are none.
Exports to European Markets — House of Commons, 2022-06-16
Topic: Culture
Alison Emily Thewliss (Scottish National Party, Centre-left): The Royal Scottish National Orchestra is one of Scotland’s great cultural exports. It has its own specialist vehicle for touring, but Brexit red tape and cabotage rules mean that it is very difficult and expensive now for it to export its cultural wares in Europe. Can the Minister tell us what he is doing to remove the Brexit red tape that is tied around our musical industries?
Business Question — House of Commons, 2022-05-12
Topic: Health
Patricia Gibson (Scottish National Party, Centre-left): May is a very important month, and today, as well as being International Nurses Day, is the birthdate of Florence Nightingale. In addition, today is also my birthday—[Hon. Members: "Hear, hear."]—a day I share with the Chancellor of the Exchequer, although, sadly, I have celebrated 12 more birthdays than he has Even more importantly than that, May is Melanoma Awareness Month. Melanoma is the most serious type of skin cancer, and protection from ultraviolet rays is key to lowering the risk of this disease. Cancer Research UK has found that skin cancer rates have more than doubled since the 1990s. Will the Leader of the House join me in lobbying the Chancellor to reclassify sun cream as an essential healthcare item, instead of a cosmetic item, thereby exempting it from VAT and making it more affordable for more people to protect themselves from the risk of skin cancer?
Fairness at Work and Power in Communities — House of Commons, 2022-05-12
Topic: Health
Kirsty Ann Blackman (Scottish National Party, Centre-left): Unfortunately, I missed the article this morning but I will be sure to read it. Does the hon. Gentleman agree that one of the biggest issues with this scheme is the length of time it takes for decisions to be made? People are waiting a significant length of time even to get an initial contact with the vaccine damage payment scheme. Does he agree that that is one of the key things that needs to be fixed?
Executions in Saudi Arabia — House of Commons, 2022-03-14
Topic: Defense
Allan Hopkins Dorans (Scottish National Party, Centre-left): Last week, the Minister for Defence Procurement was in Riyadh at the World Defence Show, actively promoting UK arms exports to the Saudi regime. Does the Minister agree that, in light of the weekend’s mass executions, the UK Government should cease all arms trade with a regime that shows no sign of respecting human rights?
Animal Welfare (Sentience) Bill [Lords] — House of Commons, 2022-03-14
Topic: Defense
Deidre Leanne Brock (Scottish National Party, Centre-left): In reference to the reports that we requested in new clauses 2 and 3, can the Minister describe to me by what mechanism the Scottish Government or other devolved nations could express their concerns about the areas that we have raised here on animal testing, cosmetic testing and the use of animal experimentation in the Ministry of Defence? What mechanism could they use to raise those concerns with the committee and eventually encourage it potentially to produce reports on those issues?
Ukraine: UK and NATO Military Commitment — House of Commons, 2022-06-20
Topic: Defense
David Michael Doogan (Scottish National Party, Centre-left): Given the evolution of the war in Ukraine, what lessons has the Ministry of Defence learned about the enduring need for infantry to take, hold and/or defend territory? Will those lessons be input to a refresh of MOD thinking and operational strategy that drove the much-derided 10,000 cut in Army numbers in the integrated review? Those infantry will require to be supported by heavy armour and armoured fighting vehicles, but, given that the UK’s decade-old solution to the latter—Ajax—is an unfathomably challenged £5.5 billion project that is surely now on the brink of being cancelled, how has the war in Ukraine focused the Department’s attention in that regard I recently returned from Türkiye, where the Turkish Defence Minister advised NATO parliamentarians on the role that his country is playing in seeking to facilitate safe passage of merchant vessels into and out of Ukraine with grain. What dynamic is the UK playing in that space? Does the Minister agree with the Turkish Minister’s assessment that it is the Ukrainians who—understandably —need persuading of the merits of demining those shipping lanes and ensuring that they do not then fall prey to Russian naval forces? Finally, if agreement is reached on demining, what role will the world-leading mine countermeasure professionals in the Royal Navy, many of whom are based in Scotland, play in demining those approaches to Ukraine?
UK Diagnostics Industry and Covid-19 Recovery — House of Commons, 2022-05-10
Topic: Health
James Neale Hanvey (Scottish National Party, Centre-left): I want to start by illustrating how important diagnostics and testing are, and nothing does that more clearly than the decision to discharge elderly people to care homes without testing. The Government’s answer that asymptomatic transmission was not understood properly does not excuse the fact that fundamental and standard infection control measures were not in place The Prime Minister said earlier that he wanted to create "high-wage, high-skilled jobs" that will drive economic growth across the United Kingdom. I will measure that soundbite against the Government’s performance and track record on the UK diagnostics sector. The domestic diagnostics sector should be at the vanguard of the world’s intellectual development, but the evidence does not support the Prime Minister’s claim that the Government support it. I will look at past performance in the early days of the pandemic and where we are presently as well as look to the future with the Government’s strategic plan and the opportunities that it could miss, to our shared peril My interest in the area is underscored by an NHS career spanning a quarter of a century in which infection control and management was a staple part of my responsibility. I understand the important elements of genomic and epidemiological surveillance. I first raised that with the chief medical officer in July 2020 and repeatedly explored testing with the right hon. Member for West Suffolk (Matt Hancock) when he was Secretary of State for Health and Social Care, focusing in particular on his exaggerated claims that lateral flow device tests were 99% accurate. My concerns have always been sincere. I am bringing my genuine clinical concerns to the Government’s attention yet again. This is not a political point, and I am not making a constitutional point, because many of the issues that I will talk about are as true north of the border as they are south of the border, and they are very serious There is an additional element to my interest in the case. My constituent Craig Inglis contacted me to express his concern about his investments in one of the diagnostics companies contracted by the Government to provide lateral flow devices, and he and many others watching the debate feel utterly betrayed by them because of events that I will set out in due course. The same is true of the diagnostics sector One insider told me: "There is a lot of acrimony remaining, with many UK companies saying they would not respond to the UK Government if a similar crisis arose." Now, I do not believe that they would not. I think that they would, but the good will and trust has been severely damaged, if not completely broken.
UK Diagnostics Industry and Covid-19 Recovery — House of Commons, 2022-05-10
Topic: Health
James Neale Hanvey (Scottish National Party, Centre-left): I may be professionally slanted on this, but one observation I made was that we had lots of very "academic" academics involved in the decision making at Cobra. There are some extremely capable and experienced senior nurses and emergency clinicians who deal with major incidents day in and day out, and they are the ones who understand how to run an emergency and where the gaps might be. I have a bit of a professional hero in Louise Boden. She was chief nurse at University College London Hospital and she got us through the 7/7 bombs and the Admiral Duncan pub bomb. Unfortunately I was on duty for both of those incidents, which was not pleasant, but it was important to have someone of that capability there, and I would gently suggest that the Government have someone with that kind of major incident experience in the room when planning these things in future.
National Shipbuilding Strategy — House of Commons, 2022-03-10
Topic: Defense
David Michael Doogan (Scottish National Party, Centre-left): I thank the Minister for advance sight of his statement and commend his fleet-of-foot actions in changing the range from Appledore to Glasgow to Appledore to Rosyth. That is an important correction to make The fourth from final paragraph in the Minister’s statement cuts to the chase on this issue in the way that the strategy does not when he states that it is a vision to make the UK, "the country of choice for specialist commercial and naval vessels and systems, components and technologies" Among the 80 pages of waffle and padding, the strategy alights briefly on that point, but not in the way it really should. The strategy also highlights the word "international" 31 times. I welcome the realisation that in a global economy with global supply chains the notion that we can procure every single element in the United Kingdom, while a noble ambition that we should sweat as much as we can, is naive I welcome the fact that the national strategy sets out a range of opportunities, which excellent yards all around Scotland are ready to lean into and capitalise on. I am a little sceptical about whether the funding announced in the strategy will have a massive impact across all the yards in the United Kingdom, but I hope it will Scotland’s skills, as I am sure the Minister will agree, have been highlighted many times in the past decade, not least on the QE2-class ships, which are outstanding in their quality and performance, the Type 26 under construction in Glasgow and the Type 31 under build in Rosyth. He will welcome, as I do, the export success that has been achieved, with 26 going to Canada and Australia, but he will know that those are in-country builds. That is not to downplay the opportunities of intellectual property and engineering that Glasgow will enjoy from them, but does he agree that really what we need is Type 31s sold to countries that will require them to be built in Rosyth?
Childhood Cancer Outcomes — House of Commons, 2022-04-26
Topic: Health
Anum Qaisar (Scottish National Party, Centre-left): I begin my contribution to this important debate by extending my sincere congratulations to the hon. Member for Gosport (Dame Caroline Dinenage). She was very eloquent in speaking of Sophie’s legacy In the past few weeks I have been speaking to my constituent Nadia Mahjid, who lives in Airdrie and whose son Rayhan sadly died from a brain tumour. I asked Nadia what she wanted me to say, and she asked me to tell his story. These are her words: "Rayhan Majid was a happy, sweet and caring four-year-old boy… He loved sports and all things yellow including the Transformers Bumblebee and the Minions Rayhan was born in June 2013 in the midst of a heatwave and when he arrived, everybody remarked that he had brought the sunshine with him." Rayhan was "always an active and healthy boy who was rarely unwell however, in October 2017, he started having severe headaches and sporadic episodes of vomiting." As with Sophie, GPs did not detect anything and it was not until Rayhan was taken to A&E, in his case six weeks later, that the decision was taken to conduct further tests. Sadly, an aggressive and cancerous tumour was detected in his brain: "At that point the tumour had already grown…and as a result it was not able to be completely removed during surgery." Nadia says that, "the aggressive surgery left our son Rayhan unable to talk, walk or swallow", and that he "had to have a second surgery to have a shunt permanently inserted into his brain to prevent fluid build up." Devastatingly, however, "the tumour re-grew and spread immediately after surgery even before radiotherapy and chemotherapy was commenced…it was decided to press on with the original treatment plan. Our Rayhan underwent 6 weeks of radiotherapy at the highest dose permitted for a child his age." The radiotherapy "had no positive impact on Rayhan’s cancer either, a post treatment MRI scan showed the disease to be present and even more widespread than it was to begin with. The final treatment offered for our son Rayhan was high dose chemotherapy… A few hours after receiving his first dose of chemotherapy drugs, Rayhan’s heart rate and breathing started to be negatively impacted as well as him developing an allergic reaction to one of the many drugs he had received that day Rayhan tragically died a cruel, slow and painful death over the course of the 5 days of chemotherapy treatment, at the end our son was completely paralysed and unable to talk or even blink his eyes Rayhan was our ‘little ray of sunshine’. His light was cruelly extinguished by a relentless disease" I have a number of questions for the Minister, but she graciously offered to meet me after I wrote to the Prime Minister, so I will ask just one as I am pressed for time right now. Does she accept calls from Cancer Research UK that the UK Government should commit to maintaining a regulatory environment that facilitates international cancer studies, including a commitment to maintain the UK-EU data adequacy agreement and the compatibility of UK and EU trial regulations?
Childhood Cancer Outcomes — House of Commons, 2022-04-26
Topic: Health
Kirsten Frances Oswald (Scottish National Party, Centre-left): I have spoken previously about a fine young man from East Renfrewshire called Daniel Caplan, who passed away at the end of 2020 aged 17, having been diagnosed with diffuse midline glioma. His brave family have kept raising awareness and funds in the memory of their lovely boy. Every nine days, a UK family gets that particular diagnosis for their child, which is devastating Another local family has a teenage daughter who is undergoing treatment for leukaemia. Her father made a number of important points that I would like to put on the record. For example, some current therapies for cancers, including types of leukaemia, are particularly onerous and can lead to challenging side effects in the long term. A lack of research means that in some areas, treatment and care has barely advanced in 40 years, so research is very much needed. He also made the point that professionals in the field are doing tremendous work, but they need more backup. Charities are taking on too much of the heavy lifting, and we need a Government commitment to that specific research I would like to make most of my remarks in relation to one wee girl from Barrhead, because recently so many people there have been in touch to ask me to raise the case of little River. I have heard from River’s mum, Katie, and am grateful that she spoke to me. When she first got in touch, she wrote: "If you ever had to live on a child’s cancer ward, anyone would soon realise that childhood cancer isn’t that rare. They deserve so much more than 3% government funding." She also said that she really appreciated my speaking about little River. I am glad to speak about the wee girl and know that everyone in the Chamber will want to send their best wishes to River, her family and the other families that I have mentioned Little River is only two, and she was diagnosed with a brain tumour last September. She has been through surgery, she is going through intense chemotherapy and she will need further treatment. She is also in intense physio rehab. She is really going through the mill, but she is ploughing on with the love and support of her family. However, even when understandably her mum could be focused only on River, she points out that she is thinking of not only her girl but all the other children who would benefit from greater emphasis on research. That better treatment and increased knowledge can come only with better research River is being treated at the Schiehallion ward at the Queen Elizabeth University Hospital. Her mum says that the staff there are so lovely, which I know is true—I have heard it so often before—and we are all grateful to staff across the UK for the outstanding work that they do. But, fundamentally, none of us can disagree that we need a commitment to further research, because, without that, we will not see the better outcomes, the better treatment and the better ways forward that these children and their families deserve.
Childhood Cancer Outcomes — House of Commons, 2022-04-26
Topic: Health
James Neale Hanvey (Scottish National Party, Centre-left): I pay tribute to the hon. Member for Gosport (Dame Caroline Dinenage) for securing this enormously important debate, and to the right hon. Member for Alyn and Deeside (Mark Tami) for his very moving personal account My observations are based on a lifetime working in NHS cancer care and on having led the first Teenage Cancer Trust unit at the Middlesex Hospital for a period of time—this was the world in which I existed. I hope that the Minister will pay attention to some of my observations from that career, because I think they will be useful in informing policy I agree that there is a need for an overarching strategy, but some of the problems discussed today are perennial; they have been there forever, and there really needs to be a concerted effort to address them. Unfortunately, some of them cannot just be solved with money. In addressing diagnosis, treatment and ultimately outcomes and survivorship, we need to think about why diagnosis is delayed, about why diseases are considered to be rare and about the ultimate impact on outcomes for children and young people. The reason for many late diagnoses is that most GPs never see a case of childhood cancer, let alone cancer in an adolescent, so the effort that goes into raising awareness and training may seem misplaced, given how rare an occurrence it is The other challenge is that many of the symptoms with which children present are things that GPs see day in, day out. Fevers, lumps and bumps, lethargy, pains in the tummy—all those symptoms are standard fare, so it is very difficult to cut through to the truth and identify types of cancer. The essential thing is a greater emphasis on driving awareness. It has to be a core part of any differential diagnosis when examining a child that there is always a chance that they have something much more sinister than a cough, cold or fever. It is about making sure that that is built into standard practice Another point that I would like to make, although I may run out of time, is that these diseases are incredibly rare. Because the subsets are so rare, it is very difficult to do longitudinal studies.
Childhood Cancer Outcomes — House of Commons, 2022-04-26
Topic: Health
James Neale Hanvey (Scottish National Party, Centre-left): I thank the hon. Lady for that intervention. I agree: there has been an enormous amount of work across a range of disease profiles, and I want very swiftly to name some of the key people with whom I have had the great pleasure to work in my time. Professor Jeremy Whelan has done a huge amount of work on soft tissue sarcomas and bone tumours, and Professor Andy Pearson from the Royal Marsden Hospital has done a huge amount of work as well. I also want to mention all the members of the multidisciplinary teams who make that kind of research and progress viable Let me finally say something about the bigger picture. Cancer does not exist in a bubble; it exists in the social fabric of where we live, and people with cancer, particularly children, are not immune to challenges such as the cost of living crisis. If we want to do a robust piece of work in order to make progress, it must involve research and treatment, but it must also improve the life chances of children more generally.
Topical Questions — House of Commons, 2022-06-14
Topic: Health
Questions: 2002 I heard what the Under-Secretary of State for Health and Social Care, my hon. Friend the Member for Lewes (Maria Caulfield), had to say about dentistry earlier, and I recognise the work she is doing to improve the situation. However, in northern Lincolnshire, like many other areas, we have very severe gaps in provision. Could the Minister outline what is being done to ensure that newly qualified dentists actually work in the NHS for a considerable time and that new practices are established in the areas where the need is greatest?; Many in the Scunthorpe area will remember David Hopkins, whom we sadly lost to glioblastoma. Alongside earlier diagnosis, we need improved access to the £40 million the Government have committed to brain tumour research. Will my right hon. Friend look carefully at the findings of the ongoing investigation by the all-party parliamentary group on brain tumours and do all he can to speed up access to this research funding?
Martyn Day (Scottish National Party, Centre-left): The Government have noted that Sir Robert Francis will give evidence on his work on the infected blood inquiry on 11 and 12 July, and said that they will act after hearing his evidence. What discussions has the Secretary of State had with Cabinet colleagues on the potential impact on victims’ mental health of the lengthy waiting times for compensation in relation to contaminated blood?